Race-Based Immunization Recommendations and the Potential to Reduce Health Disparities

JAMA

Volumn 291, Issue 18, 2004, Pages 2253-2255

  Davis, Matthew M ^a  

^a UNIVERSITY OF MICHIGAN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HAEMOPHILUS INFLUENZAE TYPE B VACCINE; INFLUENZA VACCINE; PNEUMOCOCCUS CONJUGATE VACCINE; PNEUMOCOCCUS VACCINE; UNCLASSIFIED DRUG; HEPTAVALENT PNEUMOCOCCAL CONJUGATE VACCINE; MENINGOCOCCUS VACCINE;

AFRICAN AMERICAN; AMERICAN INDIAN; CAUCASIAN; CHRONIC DISEASE; EDITORIAL; ETHNIC DIFFERENCE; HEALTH CARE QUALITY; HEALTH SURVEY; HERD IMMUNITY; HISPANIC; HUMAN; IMMUNIZATION; INCIDENCE; INFLUENZA; INFLUENZA VACCINATION; PRIORITY JOURNAL; RACE DIFFERENCE; STREPTOCOCCUS INFECTION; UNITED STATES; ETHNOLOGY; HEALTH CARE DELIVERY; NOTE; UTILIZATION REVIEW; VACCINATION;

HEALTH SERVICES ACCESSIBILITY; HUMANS; MENINGOCOCCAL VACCINES; PNEUMOCOCCAL VACCINES; STREPTOCOCCAL INFECTIONS; UNITED STATES; VACCINATION;

EID: 2342497176     PISSN: 00987484     EISSN: None     Source Type: Journal    
DOI: 10.1001/jama.291.18.2253     Document Type: Editorial

References (18)

1. Department of Health and Human Services. National Healthcare Disparities Report 2003. Available at: http://www.qualitytools.ahrq.gov/disparities report/documents/Report%207.pdf. Accessed April 8, 2004.
2. Centers for Disease Control and Prevention. Influenza vaccination coverage among adults aged > or=50 years and pneumococcal vaccination coverage among adults aged > or=65 years-United States, 2002. MMWR Morb Mortal Wkly Rep. 2003;52:987-992.
3. Department of Health and Human Services. Healthy People 2010. Vol 1. 2nd ed. Washington, DC: US Dept of Health and Human Services; November 2000.
4. Centers for Disease Control and Prevention. Racial/ethnic disparities in influenza and pneumococcal vaccination levels among persons aged > or=65 years-United States, 1989-2001. MMWR Morb Mortal Wkly Rep. 2003;52:958-962.
5. Singleton JA, Greby SM, Wooten KG, Walker FJ, Strikas R. Influenza, pneumococcal, and tetanus toxoid vaccination of adults-United States, 1993-1997. MMWR CDC Surveill Summ. 2000;49:39-62.
6. Robinson KA, Baughman W, Rothrock G, et al. Epidemiology of invasive Streptococcus pneumoniae infections in the United States, 1995-1998: opportunities for prevention in the conjugate vaccine era. JAMA. 2001;285:1729-1735.
7. Flannery B, Schrag S, Bennett NM, et al. Impact of childhood vaccination on racial disparities in invasive Streptococcus pneumoniae infections, 1998-2002. JAMA. 2004;291:2197-2203.
8. Advisory Committee on Immunization Practices. Preventing pneumococcal disease among infants and young children: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep. 2000;49(RR-9):1-35.
9. American Academy of Pediatrics, Committee on Infectious Diseases. Policy statement: recommendations for the prevention of pneumococcal infections, including the use of pneumococcal conjugate vaccine (Prevnar), pneumococcal polysaccharide vaccine, and antibiotic prophylaxis. Pediatrics. 2000;106:362-366.
10. Davis MM, Patel MS, Gebremariam A. Decline in varicella-related hospitalizations and expenditures for children and adults after introduction of varicella vaccine in the United States. Pediatrics. In press.
11. Prevention of hepatitis A through active or passive immunization: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep. 1999;48(RR-12):1-37.
12. Centers for Disease Control and Prevention. National immunization survey: Immunization coverage in the US, January-December 2002. Available at: http://www.cdc.gov/nip/coverage/NIS/02/toc-02.htm. Accessed April 8, 2004.
13. Centers for Disease Control and Prevention. Estimated vaccination coverage with individual vaccines and vaccination series among children 19-35 months of age by race/ethnicity-US, National Immunization Survey, Q1/1997-Q4/1997. Available at: http://www.cdc.gov/nip/coverage/NIS/97/TAB30-race_nat.xls. Accessed April 8, 2004.
14. Centers for Disease Control and Prevention. Recommendation of the Immunization Practices Advisory Committee update: prevention of Haemophilus influenzae type b disease. MMWR Morb Mortal Wkly Rep. 1988;37:13-16.
15. Broome CV. Epidemiology of Haemaphilus influenzae type b infections in the United States. Pediatr Infect Dis J. 1987;6:779-782.
16. Parke JC, Schneerson R, Robbins JB. The attack rate, age incidence, racial distribution, and case fatality rate of Hemophilus influenzae type b meningitis in Mecklenburg County, North Carolina. J Pediatr. 1972;81:765-769.
17. Tarr PI, Peter G. Demographic factors in the epidemiology of Hemophilus influenzae meningitis in young children. J Pediatr. 1978;92:884-888.
18. Centers for Disease Control and Prevention. Progress toward eliminating Haemophilus influenzae type b disease among infants and children-United States, 1987-1997. MMWR Morb Mortal Wkly Rep. 1998;47:993-998.